Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT03256045 · TERMINATED
Trial details
- NCT number
- NCT03256045
- Sponsor
- University of Washington
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-08
- Primary completion
- 2021-02-05
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.